Digestive discomfort, acidity, heartburn, bloating and post-meal fullness are common gastrointestinal complaints that can affect daily comfort and quality of life. When acid reflux is accompanied by symptoms related to disturbed gastric motility, a combination approach may be considered by healthcare professionals. Sinorab-IT from Sanovia Biotech combines Rabeprazole Sodium 20 mg with Itopride HCl 150 mg (SR) to provide a targeted approach to acid-related and motility-associated gastrointestinal symptoms.
Rabeprazole belongs to the proton pump inhibitor (PPI) class and works by reducing the production of gastric acid. Itopride is a prokinetic medicine used for gastrointestinal symptoms associated with reduced motility and functional dyspepsia.
Sinorab-IT Composition
Each Sinorab-IT formulation contains:
- Rabeprazole Sodium 20 mg
- Itopride HCl 150 mg (SR)
The combination brings together acid suppression and prokinetic activity, making it relevant in the management of selected patients with acid reflux and associated upper gastrointestinal symptoms, as determined by a healthcare professional.
Uses of Sinorab-IT
Sinorab-IT may be prescribed for gastrointestinal conditions such as:
- Gastroesophageal Reflux Disease (GERD)
- Acid reflux and heartburn
- Acid-related upper gastrointestinal discomfort
- Functional dyspepsia associated with fullness and discomfort
- Post-meal fullness and early satiety
- Bloating and related digestive discomfort
- Selected peptic-ulcer-related conditions as advised by a physician
Rabeprazole is established for the treatment of symptomatic GERD and healing of erosive or ulcerative GERD. It may also be used in certain ulcer-related treatment regimens.
Itopride is used for gastrointestinal symptoms associated with reduced gastrointestinal motility and functional dyspepsia, including bloating, postprandial fullness, upper abdominal discomfort, nausea and early satiety.
Key Benefits of Sinorab-IT
1. Helps Control Excess Gastric Acid
Rabeprazole reduces gastric acid secretion by inhibiting the proton pump responsible for acid production in the stomach. This acid-control action can help relieve acid-related symptoms such as heartburn and reflux.
2. Supports Better Gastrointestinal Motility
Itopride is a prokinetic agent used in conditions associated with reduced gastrointestinal motility. It can be particularly relevant when symptoms such as post-meal fullness, bloating and upper abdominal discomfort are present.
3. Dual-Action Approach
The combination of Rabeprazole and Itopride addresses two important components of upper gastrointestinal discomfort: gastric acid secretion and gastrointestinal motility. This makes the combination clinically relevant for appropriately selected patients with overlapping acid-reflux and dyspeptic symptoms.
4. Relevant for GERD and Dyspeptic Symptoms
GERD commonly presents with symptoms such as heartburn and acid reflux, while functional dyspepsia can involve epigastric discomfort, early satiety and postprandial fullness. Clinical research has evaluated rabeprazole and itopride in functional dyspepsia, highlighting the relevance of both therapeutic approaches in selected gastrointestinal patients.
Why Choose Sinorab-IT from Sanovia Biotech?
Sanovia Biotech is an emerging pharmaceutical company based in the Dera Bassi industrial hub, offering a broad portfolio across tablets, capsules, injections, syrups, nutraceuticals and herbal formulations. The company states that its products are developed with a focus on quality assurance, affordability and ethical pharmaceutical practices.
Sanovia Biotech also highlights stringent quality control and adherence to GMP, WHO and industry standards, along with its PCD Pharma Franchise and third-party manufacturing capabilities.
With its focus on reliable pharmaceutical solutions, Sinorab-IT represents Sanovia Biotech’s commitment to providing quality-oriented gastrointestinal care products for healthcare professionals and patients.
How Sinorab-IT Works
Rabeprazole works by decreasing the amount of acid produced in the stomach, helping control acid-related symptoms and supporting healing in certain acid-related disorders.
Itopride works as a prokinetic agent and is used to support gastrointestinal motility in conditions such as functional dyspepsia.
Together, the two components offer a complementary approach for patients whose symptoms involve both acid-related problems and gastrointestinal motility disturbances.
Important Information
Sinorab-IT should be used only on the advice of a qualified healthcare professional. The appropriate dose and duration depend on the patient’s condition, medical history and response to treatment. Patients should follow the prescribed directions and should not change the dose or duration without medical advice.
Persistent heartburn, severe abdominal pain, difficulty swallowing, unexplained weight loss, vomiting blood or black stools require prompt medical evaluation rather than self-medication.
Conclusion
Sinorab-IT – Rabeprazole Sodium 20 mg + Itopride HCl 150 mg (SR) is a combination designed to address important aspects of upper gastrointestinal disorders, particularly acid-related symptoms and gastrointestinal motility-associated discomfort. With the acid-suppressing action of Rabeprazole and the prokinetic role of Itopride, the formulation provides a clinically relevant combination for appropriately selected patients.
Backed by Sanovia Biotech, a growing pharmaceutical company focused on quality healthcare solutions, Sinorab-IT adds value to the company’s gastrointestinal therapeutic portfolio.
For more information about Sinorab-IT and Sanovia Biotech’s pharmaceutical product range,
visit: www.sanoviabiotech.com
